Results 41 to 50 of about 8,176 (221)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension. [PDF]

open access: yes, 2010
Glaucoma is a collection of diseases characterized by multifactorial progressive changes leading to visual field loss and optic neuropathy most frequently due to elevated intraocular pressure (IOP).
Bell, Nicholas P   +2 more
core   +3 more sources

Neuroprotective properties of Brimonidine

open access: yesОфтальмохирургия, 2019
Purpose. To summarize relevant data from publications appearing in the peer-reviewed scientific literature since1991 about mechanisms of neurodegeneration in glaucoma and the possibilities of neuroprotection; in particular, analysis of the results of ...
Т. N. Mikhailova
doaj   +1 more source

Risk Factors for Optic Disc Hemorrhage in the Low-Pressure Glaucoma Treatment Study [PDF]

open access: yes, 2014
PurposeTo investigate risk factors for disc hemorrhage detection in the Low-Pressure Glaucoma Treatment Study.DesignCohort of a randomized, double-masked, multicenter clinical trial.MethodsLow-Pressure Glaucoma Treatment Study patients with at least 16 ...
De Moraes, Carlos Gustavo   +7 more
core   +1 more source

Controlling the Adsorption and Release of Ocular Drugs in Metal–Organic Frameworks: Effect of Polar Functional Groups [PDF]

open access: yes, 2022
A series of UiO-66 materials with different functional groups (−H, −NH2, and −NO2) have been evaluated for the adsorption and release of a common ocular drug such as brimonidine tartrate.
Farrando Pérez, Judit   +6 more
core   +1 more source

A Topical Formulation of Melatoninergic Compounds Exerts Strong Hypotensive and Neuroprotective Effects in a Rat Model of Hypertensive Glaucoma [PDF]

open access: yes, 2020
Melatonin is of great importance for regulating several eye processes, including pressure homeostasis. Melatonin in combination with agomelatine has been recently reported to reduce intraocular pressure (IOP) with higher efficacy than each compound alone.
Amato, Rosario   +6 more
core   +1 more source

Ocular metabolism and distribution of drugs in the rabbit eye : Quantitative assessment after intracameral and intravitreal administrations [PDF]

open access: yes, 2022
Quantitation of ocular drug metabolism is important, but only sparse data is currently available. Herein, the pharmacokinetics of four drugs, substrates of metabolizing enzymes, was investigated in albino rabbit eyes after intracameral and intravitreal ...
del Amo, Eva M.   +11 more
core   +1 more source

Nummular keratitis: A rare manifestation of brimonidine allergy

open access: yesOman Journal of Ophthalmology
A 32-year-old male, with juvenile open-angle glaucoma on chronic antiglaucoma therapy and recently introduced brimonidine eye drops to the treatment regimen, developed bilateral follicular conjunctivitis with subepithelial infiltrates (SEIs) initially ...
Maitha Al Asmi, Aisha Al Busaidi
doaj   +1 more source

Topical brimonidine induced acute uveal effusion in a patient with nanophthalmos: a case report

open access: yesBMC Ophthalmology, 2023
Background We report a case of uveal effusion in a nanophthalmic eye after topical use of brimonidine. Case presentation A 42-year-old male patient with nanophthalmos experienced sudden blurred vision in the right eye after using topical brimonidine when
Yakun Li, Qi Zhou
doaj   +1 more source

Effect of brimonidine on central corneal thickness in normal tension glaucoma patients [PDF]

open access: yes, 2019
Background: Brimonidine is a potent ocular hypotensive agent widely used in glaucoma treatment. A reduction in central corneal thickness can lead to an underestimation of intraocular pressure by Goldmann applanation tonometry and vice versa.
K., Praveena K.   +2 more
core   +2 more sources

A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension

open access: yesIndian Journal of Ophthalmology, 2014
Aims: The aim was to compare efficacy and cost-effectiveness of bimatoprost 0.03% and brimonidine 0.2% in primary open-angle glaucoma (POAG)/ocular hypertension (OHT). Settings and Design: Open, randomized, cross-over, comparative study.
Navreet Kaur Natt   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy